| name | pdx-model-analysis-agent |
| description | AI-powered analysis of patient-derived xenograft (PDX) models for drug response prediction, translational research, and personalized treatment selection. |
PDX Model Analysis Agent
The PDX Model Analysis Agent provides AI-driven analysis of patient-derived xenograft models for preclinical drug testing, translational research, and personalized oncology. It correlates PDX drug responses with patient outcomes and molecular profiles for treatment selection.
When to Use This Skill
- When selecting drug treatments based on PDX drug response data.
- To correlate PDX molecular profiles with patient tumor characteristics.
- For analyzing PDX-patient concordance in drug sensitivity.
- When designing preclinical drug combination studies.
- To identify biomarkers predicting PDX and patient drug response.
Core Capabilities
-
PDX-Patient Concordance: Analyze molecular similarity between PDX and donor tumor.
-
Drug Response Modeling: ML models correlating PDX drug sensitivity to patient outcomes.
-
Biomarker Discovery: Identify molecular features predicting drug response in PDX panels.
-
Combination Screening: Analyze synergy in PDX drug combination studies.
-
Translational Prediction: Project PDX findings to patient treatment selection.
-
Quality Assessment: Evaluate PDX fidelity and stability across passages.
PDX Quality Metrics
| Metric | Threshold | Interpretation |
|---|
| Genetic concordance | >90% |
